|   | 
										시장보고서
									 
											
												상품코드
											
										 
											1740822
										 세계의 바이폴라 전기 수술기기 시장 : 기회, 성장 촉진요인, 산업 동향 분석, 예측(2025-2034년)Bipolar Electrosurgical Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 | ||||||
세계 바이폴라 전기 수술기기 시장은 2024년에는 44억 달러로 평가되었으며 CAGR 5.2%로 성장했으며 2034년에는 72억 달러에 이를 것으로 추정됩니다.
저침습 수술에 대한 수요가 환자와 외과 의사들 사이에서 높아지는 가운데, 바이폴라 전기 수술은 현대 수술 워크 플로우에 필수적입니다. 현재 진행중인 저침습 접근으로의 전환은 병원과 수술센터에서 바이폴라 전기 수술 기술의 채용을 크게 증가시키고 있습니다.

바이폴라 전기 수술기기는 주위 조직에 대한 위험을 억제하면서 탁월한 정밀도로 절단과 응고를 모두 수행하도록 설계되어 있습니다. 정밀도와 조직 보전에 대한 주목의 고조는 신경외과, 정형외과, 부인과 등의 외과 분야에서의 사용 확대를 지지해, 시장 확대를 한층 더 밀어주고 있습니다.
| 시장 범위 | |
|---|---|
| 시작 연도 | 2024년 | 
| 예측 연도 | 2025-2034년 | 
| 시작 금액 | 44억 달러 | 
| 예측 금액 | 72억 달러 | 
| CAGR | 5.2% | 
이 장치는 바이폴라 구성을 통해 적용되는 고주파 전기 에너지를 사용하여 작동합니다. 이 중 바이폴라 전기 수술 발전기는 2024 년에 47.2%로 가장 높은 판매 점유율을 차지합니다. 핵심이 되는 에너지원으로서 기능해, 모든 전기외과 셋업에 불가결한 것이 되고 있습니다.
바이폴라 전기 수술 도구는 또한 집게, 가위, 프로브 또는 전극으로 나뉩니다. 제너레이터는 자본 집약적이며 시스템 기능에 필수적이기 때문에 제품 기반 세분화에서는 지배적인 지위를 유지하고 있습니다.
용도별로는 일반외과, 뇌신경외과, 심혈관외과, 부인과외과, 기타 전문분야로 분류됩니다. 고령자는 변성 질환이나 만성 질환의 빈도가 높기 때문에 외과 수술을 받을 가능성이 높고, 바이폴라 장치와 같은 신뢰성이 높고 안전한 수술 기구 수요를 밀어 올리고 있습니다. 정확한 절개를 가능하게 하는 효율성에 의해 일반 수술에서 좋아해 사용되고 있습니다.
최종 사용자별로는 시장은 병원, 외래수술센터, 전문클리닉, 학술기관 및 연구기관으로 구분됩니다. 바이폴라 장비는 열 확산의 최소화, 출혈 감소, 우발적인 화상 감소와 같은 주요 이점을 제공하며 더 나은 임상 결과와 치료 기간 단축을 지원합니다.
지역별로는 북미가 시장 동향의 형성에 매우 중요한 역할을 하고 있습니다. 습관병이 급증하고 수술 건수가 증가하고 있습니다. 만성 질환이 만연함에 따라 효율적이고 정확도가 높은 수술 기구의 필요성이 높아지고 있습니다.
경쟁 구도으로는 세계 기업과 지역 기업이 혼재하여 높아지는 수술 수요에 대응한 솔루션을 제공합니다. 연속성을 유지하기 위해 지속적인 기술 혁신, 제품 맞춤화, 가격 전략을 통해 경쟁하고 있습니다.
The Global Bipolar Electrosurgical Devices Market was valued at USD 4.4 billion in 2024 and is estimated to grow at a CAGR of 5.2% to reach USD 7.2 billion by 2034. As the demand for minimally invasive procedures gains momentum among patients and surgeons alike, bipolar electrosurgery has become an integral part of modern surgical workflows. These procedures offer substantial benefits, including smaller incisions, reduced blood loss, quicker discharge times, and faster recovery. The ongoing shift towards minimally invasive approaches has significantly increased the adoption of bipolar electrosurgical technologies in hospitals and surgical centers.

Bipolar electrosurgical instruments are designed to perform both cutting and coagulation with exceptional precision while limiting harm to the surrounding tissue. This translates to a lower rate of post-operative infections and complications. With advancements in vessel sealing capabilities, improved thermal control, and ergonomic tool designs, these instruments continue to enhance procedural outcomes. The heightened focus on precision and tissue conservation supports their growing use in surgical fields such as neurosurgery, orthopedics, gynecology, and others, further driving market expansion. The adoption of newer devices compatible with robotic and laparoscopic systems also reinforces their position in standardized surgical protocols.
| Market Scope | |
|---|---|
| Start Year | 2024 | 
| Forecast Year | 2025-2034 | 
| Start Value | $4.4 Billion | 
| Forecast Value | $7.2 Billion | 
| CAGR | 5.2% | 
These devices operate using high-frequency electrical energy applied through a bipolar configuration, where the current flows only through the tissue between two forceps-like electrodes. This design ensures localized energy delivery and minimal tissue trauma. The market is segmented based on product types, with categories including bipolar electrosurgical generators, bipolar electrosurgical instruments, and accessories and consumables. Among these, bipolar electrosurgical generators accounted for the highest revenue share at 47.2% in 2024. These generators act as the core energy source for all connected instruments and accessories, making them essential for any electrosurgical setup. Their high cost compared to reusable instruments and accessories contributes significantly to overall market revenue.
Bipolar electrosurgical instruments are further divided into forceps, scissors, and probes or electrodes. While these tools are widely used across various surgical procedures, their affordability relative to generators places them as mid-level revenue contributors within the segment. Generators, being capital-intensive and indispensable for system functionality, maintain a dominant hold on product-based segmentation.
Based on application, the market is categorized into general surgery, neurosurgery, cardiovascular surgery, gynecological surgery, and other specialized fields. General surgery led the segment with a market share of 40.4% in 2024. The prevalence of age-related conditions such as gallbladder disease, appendicitis, and hernias has grown alongside the expanding global elderly population. Older adults are more likely to undergo surgical procedures due to the higher frequency of degenerative and chronic illnesses, which boosts the demand for reliable and safe surgical tools like bipolar devices. Their efficiency in managing bleeding and enabling precise incisions makes them a preferred choice across general surgery departments.
By end user, the market is segmented into hospitals, ambulatory surgical centers, specialty clinics, and academic or research institutions. Hospitals dominated this segment, with revenue amounting to USD 2.5 billion in 2024. Their focus on enhancing patient safety, improving procedural accuracy, and reducing recovery time has spurred investments in advanced surgical equipment. Bipolar devices offer key advantages such as minimal thermal spread, reduced bleeding, and fewer accidental burns, supporting better clinical outcomes and shorter procedure durations. As hospitals continue to upgrade to equipment that is compatible with cutting-edge surgical systems, including robotics and laparoscopic tools, the demand for bipolar electrosurgical devices is expected to climb.
Regionally, North America plays a pivotal role in shaping market trends. The bipolar electrosurgical devices market in the United States alone is projected to rise from USD 1.8 billion in 2024 to USD 2.9 billion by 2034. A surge in lifestyle-related diseases, including cardiovascular disorders, diabetes, and obesity, has led to a growing number of surgeries. As chronic conditions become more prevalent, the need for efficient, precision-driven surgical instruments becomes more pressing. Bipolar electrosurgical units meet these clinical demands effectively, reinforcing their value across U.S. healthcare facilities.
The competitive landscape of the bipolar electrosurgical devices market features a blend of global and regional players offering tailored solutions to meet rising surgical demands. Leading companies such as Medtronic, Johnson & Johnson, B. Braun, Stryker, and Olympus together represent approximately 65% of the global market. These organizations compete through continuous innovation, product customization, and pricing strategies to maintain relevance across both developed and emerging markets. In cost-sensitive regions, domestic players challenge multinational brands by delivering affordable, quality devices, prompting global leaders to adapt their approach while ensuring compliance with safety and performance standards.